We are live on ! Find out more
TELA icon

TELA Bio
TELA

45 hedge funds and large institutions have $165M invested in TELA Bio in 2021 Q2 according to their latest regulatory filings, with 10 funds opening new positions, 15 increasing their positions, 14 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

12% more capital invested

Capital invested by funds: $147M → $165M (+$17.4M)

2.41% more ownership

Funds ownership: 68.5% → 70.91% (+2.4%)

7% more repeat investments, than reductions

Existing positions increased: 15 | Existing positions reduced: 14

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

4% less funds holding

Funds holding: 47 → 45 (-2)

17% less first-time investments, than exits

New positions opened: 10 | Existing positions closed: 12

Holders
45
Holders Change
-2
Holders Change %
-4.26%
% of All Funds
0.78%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
10
Increased
15
Reduced
14
Closed
12
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
PVI
Pura Vida Investments
New York
+$4.61M
2
GPCM
Granite Point Capital Management
Massachusetts
+$2.74M
3
SAM
Silvercrest Asset Management
New York
+$2.19M
4
PHP
Parkman Healthcare Partners
Connecticut
+$1.37M
5
OM
Opaleye Management
Massachusetts
+$1.03M

Top Sellers

1
BlackRock
BlackRock
New York
-$3.98M
2
Alyeska Investment Group
Alyeska Investment Group
Illinois
-$3.5M
3
State Street
State Street
Massachusetts
-$1.16M
4
Vanguard Group
Vanguard Group
Pennsylvania
-$1.06M
5
Northern Trust
Northern Trust
Illinois
-$851K
Name Holding Trade Value Shares
Change 		Change in
Stake
O
1
OrbiMed
New York
$48.8M – – –
EWM
2
Essex Woodlands Management
Texas
$25.5M – – –
RI
3
RTW Investments
New York
$22.4M +$138K +10,091 +0.7%
PVI
4
Pura Vida Investments
New York
$12.2M +$4.61M +336,322 +80%
OM
5
Opaleye Management
Massachusetts
$7.1M +$1.03M +75,465 +21%
SAM
6
Silvercrest Asset Management
New York
$6.48M +$2.19M +159,530 +66%
CAC
7
Cowen and Company
New York
$6.3M -$138K -10,091 -3%
Vanguard Group
8
Vanguard Group
Pennsylvania
$5.51M -$1.06M -77,240 -18%
PCM
9
Pentwater Capital Management
Florida
$4.86M +$368K +26,834 +10%
AC
10
Armistice Capital
New York
$4.25M +$192K +14,000 +6%
GPCM
11
Granite Point Capital Management
Massachusetts
$3.22M +$2.74M +200,000 New
SSA
12
Schonfeld Strategic Advisors
New York
$2.21M +$239K +17,467 +15%
SMH
13
Sanders Morris Harris
Texas
$1.95M -$21.1K -1,539 -1%
JAMONY
14
Jacob Asset Management of New York
California
$1.66M – – –
PHP
15
Parkman Healthcare Partners
Connecticut
$1.61M +$1.37M +100,000 New
BCM
16
Bridgeway Capital Management
Texas
$1.4M +$566K +41,300 +90%
Geode Capital Management
17
Geode Capital Management
Massachusetts
$1.03M -$459K -33,468 -34%
Millennium Management
18
Millennium Management
New York
$984K +$593K +43,237 +242%
Two Sigma Investments
19
Two Sigma Investments
New York
$910K +$774K +56,488 New
PNC Financial Services Group
20
PNC Financial Services Group
Pennsylvania
$760K – – –
Renaissance Technologies
21
Renaissance Technologies
New York
$735K +$228K +16,600 +57%
Nomura Holdings
22
Nomura Holdings
Japan
$698K -$89.1K -6,500 -13%
Two Sigma Advisers
23
Two Sigma Advisers
New York
$564K +$480K +35,000 New
JG
24
Jefferies Group
New York
$564K +$480K +35,000 New
WP
25
WMS Partners
Maryland
$440K – – –
1
2 3

TELA Hedge Fund Activity: Q2 2021 in Review

45 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in TELA Bio (TELA) for Q2 2021, worth a combined $165M — up 12% from $147M a quarter earlier.

Sellers outnumbered buyers: 12 funds closed out of TELA and 10 opened new positions — a net loss of 2 holders — while 14 trimmed existing stakes and 15 added.

The largest buyer was Pura Vida Investments, adding an estimated $4.61M. The largest seller was BlackRock, cutting an estimated $3.98M.

  • 45 institutional investors held TELA Bio (TELA) as of Q2 2021, down from 47 in Q1 2021.
  • Funds reported $165M of TELA Bio stock for Q2 2021, up 12% quarter-over-quarter.
  • 10 funds opened new TELA Bio positions in Q2 2021 and 12 closed out, a net change of -2 holders.
  • The largest TELA Bio buyer in Q2 2021 was Pura Vida Investments, an estimated $4.61M added.
  • The largest TELA Bio seller in Q2 2021 was BlackRock, an estimated $3.98M sold.

Based on aggregated 13F filings for Q2 2021.